Important Safety Information
Steps to take prior to treatment1
You may be at increased risk for certain infections during Soliris treatment. As a safety precaution, patients must be vaccinated against meningococcal infection before starting Soliris. Your physician or nurse will make sure you receive this vaccine at least 2 weeks before your first infusion. Your doctor will provide you with the tools and information you will need to identify and take early action if you suspect that you have a meningococcal infection.
Your doctor or healthcare provider will provide you with a Patient Safety Information Card to carry with you at all times. This safety card contains important safety information that you need to be aware of before you are given Soliris and during your treatment with Soliris. Show this card to any doctor involved in your treatment.
Soliris treatment may reduce your natural resistance to infections, especially meningococcal infection, which requires immediate medical attention. If you experience any of the following symptoms, you should immediately call your doctor.
- Headache with nausea and/or vomiting
- Headache and fever
- Headache with a stiff neck or back
- Fever of 103°F (39.4°C) or higher
- Fever and a rash
- Confusion
- Severe muscle aches with flu-like symptoms
- Sensitivity to light
If you cannot reach your doctor, go to an emergency room immediately and show them your Patient Safety Information Card.
Even if you stop using Soliris, keep this card with you for 3 months after the last Soliris dose, since side effects may occur a long time after your last dose of Soliris.